N9,N10-Diphenyl-N9,N10-di-m-tolylanthracene-9,10-diamine , 95+% , 189263-81-8

Synonym(s):
tPA

CAS NO.：189263-81-8

Empirical Formula: C40H32N2

Molecular Weight: 540.7

MDL number: MFCD00166068

PRODUCT Properties

• Melting point: 262 °C
• Boiling point: 723.8±53.0 °C(Predicted)
• Density: 1.194±0.06 g/cm3(Predicted)
• storage temp.: 2-8°C
• pka: -0.33±0.50(Predicted)
• form: Lyophilized
• color: Light yellow to Yellow to Orange

Description and Uses

Tissue plasminogen activator has been used in a study to assess treatment risks of intracranial hemorrhage among patients with acute ischemic stroke. Tissue plasminogen activator has also been used in a study to investigate the successful treatment of early thrombosis of HeartWare left ventricular assist devices with intraventricular thrombolytics. Human tissue plasminogen activator has been used to study the effect of tyrosinase-related protein 2 (TRP-2) expression on melanin production in sheep.

Safety

• Symbol(GHS): GHS07
• Signal word: Warning
• Hazard statements: H315-H319-H335
• Precautionary statements: P261-P305+P351+P338
• Hazard Codes: Xn
• Risk Statements: 22-36/37/38
• Safety Statements: 26-36
• WGK Germany: 1
• HS Code: 2921.59.8090